🔗 Permalink

Inventor profile of:

Jérôme Aubert

City:

Grasse

Country:

France

Published Applications:

38

Last publication date:

2019-08-08

Top Assignees for applications by Jérôme Aubert

The entities that hold a legal rights for patent applications filed by inventor Aubert Jérôme:

GALDERMA RESEARCH &DEVELOPMENT 32 BIOT, France
UNIVERSITAT MUNSTER 2 Munster, Germany
GALMERMA RESEARCH & DEVELOPMENT 1 Biot, France
GALDERMA RESEARCH & DEVELOPMENT, S.N.C. 1 Valbonne Sophia Antipolis, France
GLADERMA RESEARCH & DEVELOPMENT 1 Biot, France
C.N.R.S. 1 Paris, France

Recent patent applications by Aubert Jérôme

Jérôme Aubert from Grasse, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-08-08

US20190242874A1

HUMAN EPITHELIAL CELL LINE FOR 3-D MODELIZING OF CANCER AND TREATMENT THEREOF

#2 | 2017-02-02

US20170027922A1

Human necessities

Use of naratriptan in the treatment of rosacea

#3 | 2017-01-26

US20170023549A1

HUMAN EPITHELIAL CELL LINE FOR 3-D MODELIZING OF CANCER AND TREATMENT THEREOF

#4 | 2016-12-15

US20160362403A1

Chemistry; metallurgy

Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases

#5 | 2016-06-16

US20160166562A1

Human necessities

Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases

#6 | 2016-01-07

US20160000800A1

Human necessities

MODULATORS AND METHODS FOR THE TREATMENT OF ROSACEA

#7 | 2015-12-31

US20150374708A1

Human necessities

Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies

#8 | 2015-10-29

US20150307922A1

Chemistry; metallurgy

Method for the diagnosis of rosacea

#9 | 2015-03-26

US20150087675A1

Chemistry; metallurgy

Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases

#10 | 2014-10-16

US20140309208A1

Chemistry; metallurgy

Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies

#11 | 2014-10-02

US20140296254A1

Chemistry; metallurgy

Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases

#12 | 2014-09-18

US20140275108A1

Chemistry; metallurgy

NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS

#13 | 2014-08-28

US20140243523A1

HUMAN EPITHELIAL CELL LINE FOR 3-D MODELIZING OF CANCER AND TREATMENT THEREOF

#14 | 2014-01-30

US20140031341A1

Human necessities

MODULATORS AND METHODS FOR THE TREATMENT OF ROSACEA

#15 | 2014-01-23

US20140024725A1

Human necessities

MODULATORS FOR TRPA1 FOR THE TREATMENT OF ROSACEA

#16 | 2013-09-05

US20130231393A1

Chemistry; metallurgy

USE OF SQUARAMIDE IN THE PREVENTION AND/OR TREATMENT OF ROSACEA

#17 | 2013-01-17

US20130017969A1

Chemistry; metallurgy

MARKERS AND METHOD FOR THE DIAGNOSIS OF ROSACEA

#18 | 2013-01-03

US20130005803A1

Human necessities

USE OF COMPOUNDS IN THE TREATMENT OR PREVENTION OF SKIN DISORDERS

#19 | 2011-11-03

US20110268742A1

PCTP MODULATORS IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA

#20 | 2011-10-27

US20110263677A1

Chemistry; metallurgy

GOS2 MODULATORS IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA

#21 | 2011-10-27

US20110262451A1

MODULATORS OF ISOVALERYL-COENZYME A DEHYDROGENASE IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA

#22 | 2011-09-22

US20110229423A1

PACAP SIGNALING PATHWAY MODULATORS FOR TREATING INFLAMMATORY SKIN DISEASES HAVING A NEUROGENIC COMPONENT, NOTABLY ROSACEA, AND COMPOSITIONS COMPRISED THEREOF

#23 | 2011-09-01

US20110213009A1

ADFP MODULATORS IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA

#24 | 2011-08-04

US20110189686A1

SCREENING FOR MODULATORS OF CYP2B15 AND/OR GPD1 FOR THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA

#25 | 2011-07-07

US20110165168A1

Chemistry; metallurgy

CIDEA MODULATORS IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA

#26 | 2011-06-23

US20110150773A1

MODULATORS OF ACETYL-COENZYME A ACYLTRANSFERASE 1 OR 2 IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA

#27 | 2010-09-30

US20100247583A1

Chemistry; metallurgy

N-phenylacetamide inhibitors of the enzyme SOAT-1 and pharmaceutical/cosmetic compositions comprised thereof

#28 | 2010-09-30

US20100247468A1

Chemistry; metallurgy

Compounds that modulate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprising said compounds

#29 | 2010-09-16

US20100233718A1

Chemistry; metallurgy

NON-INVASIVE TECHNIQUE FOR CONDUCTING SKIN INFLAMMATORY DISEASE PHARMACO-GENOMIC STUDIES AND DIAGNOSES THEREOF

#30 | 2010-04-22

US20100099689A1

Chemistry; metallurgy

Methods of modulating PPAR gamma-type receptors

#31 | 2010-03-04

US20100057369A1

Corrective methodology for processing results of transcriptome experiments obtained by differential analysis

#32 | 2010-02-11

US20100035988A1

Chemistry; metallurgy

Methods for activating PPAR gamma-type receptors

#33 | 2010-02-04

US20100028879A1

Chemistry; metallurgy

Modulators of HSD17b7 for treating acne or hyperseborrhea

#34 | 2010-01-28

US20100021893A1

Modulators of lanosterol synthetase for treating acne or hyperseborrhea

#35 | 2010-01-28

US20100021892A1

Modulators of SC4MOL for treating acne or hyperseborrhea

#36 | 2009-10-01

US20090246776A1

Modulators of scarb-1 for treating acne or hyperseborrhea

#37 | 2007-05-17

US20070112070A1

Chemistry; metallurgy

Biaromatic compounds which activate PPARγ-type receptors and cosmetic/pharmaceutical compositions comprised thereof

#38 | 2006-07-06

US20060148862A1

Chemistry; metallurgy

Compounds that modulate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof

InventorID:

14231 ⎘